CIK 0001267565 · Large accelerated filer
COLLEGIUM PHARMACEUTICAL, INC
Sign in to watch- Ticker
- COLL
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- VA
- Entity type
- operating
- Phone
- 781-713-3699
- Business address
- 100 TECHNOLOGY CENTER DRIVE, STOUGHTON, MA, 02072
- Former names
- COLLEGIUM PHARMACEUTICAL INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-03-03 | Dreyer Scott EVP & Chief Commercial Officer | Sale 10b5-1 | −46,417 | $40.36 | $1.9M | 75,329 |
| 2026-03-03 | Dreyer Scott EVP & Chief Commercial Officer | Sale 10b5-1 | −3,559 | $40.99 | $146K | 71,770 |
| 2026-02-10 | Dieter David EVP & General Counsel | Grant or award | +22,194 | 91,047 | ||
| 2026-02-10 | Dieter David EVP & General Counsel | Grant or award | +9,005 | 100,052 | ||
| 2026-02-10 | Dieter David EVP & General Counsel | Shares withheld for taxes | −2,781 | $46.75 | $130K | 97,271 |
| 2026-02-10 | Tupper Colleen EVP & Chief Financial Officer | Grant or award | +26,421 | 153,088 | ||
| 2026-02-10 | Tupper Colleen EVP & Chief Financial Officer | Grant or award | +32,734 | 185,822 | ||
| 2026-02-10 | Tupper Colleen EVP & Chief Financial Officer | Shares withheld for taxes | −11,861 | $46.75 | $555K | 173,961 |
| 2026-02-10 | Tupper Colleen EVP & Chief Financial Officer | Shares withheld for taxes | −26,679 | $46.75 | $1.2M | 147,282 |
| 2026-02-10 | Smith Thomas B EVP and Chief Medical Officer | Grant or award | +14,268 | 85,312 | ||
| 2026-02-10 | Smith Thomas B EVP and Chief Medical Officer | Grant or award | +22,774 | 108,086 | ||
| 2026-02-10 | Smith Thomas B EVP and Chief Medical Officer | Shares withheld for taxes | −5,897 | $46.75 | $276K | 102,189 |
| 2026-02-10 | Smith Thomas B EVP and Chief Medical Officer | Shares withheld for taxes | −11,538 | $46.75 | $539K | 90,651 |
| 2026-02-10 | Dreyer Scott EVP & Chief Commercial Officer | Grant or award | +19,023 | 122,636 | ||
| 2026-02-10 | Dreyer Scott EVP & Chief Commercial Officer | Grant or award | +30,702 | 153,338 | ||
| 2026-02-10 | Dreyer Scott EVP & Chief Commercial Officer | Shares withheld for taxes | −9,977 | $46.75 | $466K | 143,361 |
| 2026-02-10 | Dreyer Scott EVP & Chief Commercial Officer | Shares withheld for taxes | −21,615 | $46.75 | $1.0M | 121,746 |
| 2026-02-10 | Karnani Vikram President and CEO | Grant or award | +79,264 | 176,629 | ||
| 2026-02-10 | Karnani Vikram President and CEO | Grant or award | +32,531 | 209,160 | ||
| 2026-02-10 | Karnani Vikram President and CEO | Shares withheld for taxes | −11,296 | $46.75 | $528K | 197,864 |
Page 2 of 24 · 462 trades